Francesco Gaudio

BeEAM (bendamustine, etoposide, cytarabine, melphalan) before autologous stem cell transplantation is safe and effective for resistant/relapsed lymphoma patients

Giuseppe Visani, Lara Malerba, Pietro Maria Stefani et al. · Blood · 2011 · 135 citations · Full text

Poor mobilization is an independent prognostic factor in patients with malignant lymphomas treated by peripheral blood stem cell transplantation

Vincenzo Pavone, Francesco Gaudio, Giuseppe Console et al. · Bone Marrow Transplantation · 2006 · 114 citations

Lymphoid Neoplasia, Oncology, Marrow Transplantation +14

Mobilization of peripheral blood stem cells with high-dose cyclophosphamide or the DHAP regimen plus G-CSF in non-Hodgkin's lymphoma

Vincenzo Pavone, Francesco Gaudio, Attilio Guarini et al. · Bone Marrow Transplantation · 2002 · 80 citations

Lymphoid Neoplasia, Cell Therapy, High-dose Cyclophosphamide +9

High Ki67 Index and Bulky Disease Remain Significant Adverse Prognostic Factors in Patients with Diffuse Large B Cell Lymphoma before and after the Introduction of Rituximab

Francesco Gaudio, Annamaria Giordano, Tommasina Perrone et al. · Acta Haematologica · 2011 · 64 citations

Hematological Malignancy, Lymphoid Neoplasia, Translational Medicine +15

Microvascular density, CD68 and tryptase expression in human Diffuse Large B-Cell Lymphoma

Christian Marinaccio, Giuseppe Ingravallo, Francesco Gaudio et al. · Leukemia Research · 2014 · 56 citations

Lymphoid Neoplasia, Immunology, Hematology +9